SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178253-17-000008
Filing Date
2017-05-15
Accepted
2017-05-15 08:17:33
Documents
1
Period of Report
2017-05-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_149485063942281.html 4  
1 FORM 4 wf-form4_149485063942281.xml 4 3079
  Complete submission text file 0001178253-17-000008.txt   4449
Mailing Address 101 HUDSON STREET SUITE 3610 JERSEY CITY NJ 07302-6548
Business Address 101 HUDSON STREET SUITE 3610 JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Issuer) CIK: 0001178253 (see all company filings)

IRS No.: 562181648 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SCYNEXIS, INC. 3501 C TRICENTER BOULEVARD DURHAM NC 27713
Business Address
Angulo Gonzalez David (Reporting) CIK: 0001644071 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36365 | Film No.: 17841225